Organogenesis Holdings Inc.
ORGO
$1.79
$0.031.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 18.08% | -83.89% | |||
| Total Other Revenue | -2.86% | 82.46% | |||
| Total Revenue | 17.53% | -83.50% | |||
| Cost of Revenue | -8.14% | -42.39% | |||
| Gross Profit | 75.30% | -93.67% | |||
| SG&A Expenses | -17.21% | -34.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.60% | -31.62% | |||
| Operating Income | 24.26% | -197.84% | |||
| Income Before Tax | 25.69% | -207.96% | |||
| Income Tax Expenses | 396.32% | -177.64% | |||
| Earnings from Continuing Operations | -81.10% | -221.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -81.10% | -221.64% | |||
| EBIT | 24.26% | -197.84% | |||
| EBITDA | 24.73% | -184.90% | |||
| EPS Basic | -75.69% | -258.80% | |||
| Normalized Basic EPS | 24.48% | -196.40% | |||
| EPS Diluted | -75.69% | -267.20% | |||
| Normalized Diluted EPS | 24.48% | -200.42% | |||
| Average Basic Shares Outstanding | 0.69% | 0.70% | |||
| Average Diluted Shares Outstanding | 0.69% | -3.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||